TrialMax ConMed™ Solution Overview

November 9, 2015

Do you collect concomitant medication data in your clinical trials? If yes, how accurately? If no, should you begin to? While regulators increasingly recommend that ConMeds be captured by sponsors, traditional methods relying on patient recall and EDC entry are prone to errors.

To overcome this challenge, our TrialMax Touch® eCOA solution now includes an intuitive ConMed reporting solution seamlessly embedded within it. By integrating into a patient's existing eDiary, TrialMax ConMed™ streamlines the medication reporting process, reducing the burden on patients and ensuring the most accurate data possible.

Previous
TrialMax® eCOA Solution for Asthma Clinical Trials
TrialMax® eCOA Solution for Asthma Clinical Trials

Next
TrialMax® eCOA Solution for COPD Clinical Trials
TrialMax® eCOA Solution for COPD Clinical Trials

TrialMax® for COPD trials helps reduce patient and site burden while capturing the highest quality and most...